Skip to main content

Table 1 Myositis-specific and associated autoantibody targets and significant or suggestive SNPs used in analyses

From: Systematic protein-protein interaction and pathway analyses in the idiopathic inflammatory myopathies

Autoantibody targets (n = 28)

SNPs (n = 22)

Symbol

Description

MSA/MAA

rsID

Coordinates (GRCh37 assembly)

Immunochip p value [9]

Clinical group

GARS

Glycyl-tRNA synthetase

Anti-EJ

rs5754467

Chr22:21985094

4.67 × 10-07

IIM

YARS

Tyrosyl-tRNA synthetase

Anti-Ha

rs6599390

Chr4:956047

6.48 × 10-07

IIM

HARS

Histidyl-tRNA synthetase

Anti-Jo-1

rs4853540

Chr2:191917317

1.57 × 10-06

IIM

NARS

Asparaginyl-tRNA synthetase

Anti-KS

rs10189330

Chr2:99389870

2.68 × 10-06

IIM

IARS

Isoleucyl-tRNA synthetase

Anti-OJ

rs570676

Chr11:36492191

9.42 × 10-06

IIM

AARS

Alanyl-tRNA synthetase

Anti-PL-12

rs223900

Chr16:57445376

9.97 × 10-06

IIM

TARS

Threonyl-tRNA synthetase

Anti-PL-7

rs451375

(Proxy for rs376072)

Chr3:28049889

(1.45 × 10-05)

IIM

FARSA

Phenylalanyl-tRNA synthetase, alpha subunit

Anti-Zo-α

rs3116494

Chr2:204592021

1.54 × 10-05

IIM

FARSB

Phenylalanyl-tRNA synthetase, beta subunit

Anti-Zo-β

rs11064180

Chr12:6523249

1.61 × 10-05

IIM

CHD3

Chromodomain helicase DNA binding protein 3

Anti-Mi-2α

rs2476601

Chr1:114377568

7.22 × 10-09/7.90 × 10-11

IIM/PM

CHD4 a

Chromodomain helicase DNA binding protein 4

Anti-Mi-2β

rs3094013

Chr6:31434366

6.36 × 10-76

PM

SRP54

Signal recognition particle 54 kDa

Anti-SRP

rs9905921

Chr17:71527243

2.01 × 10-06

PM

SAE1

Small ubiquitin related modifier 1 activating enzyme subunit 1

Anti-SAE-1

rs7956536

Chr12:109980516

3.66 × 10-06

PM

UBA2

Ubiquitin-like modifier activating enzyme 2

Anti-SAE-2

rs2286896

Chr2:191535576

3.76 × 10-06

PM

TRIM33

Tripartite motif containing 33

Anti-TIF1γ

rs17799348

Chr8:11333521

4.13 × 10-06

PM

TRIM24

Tripartite motif containing 24

Anti-TIF1α

rs917998

(Proxy for rs1420095)

Chr2:103068156

(6.16 × 10-06)

PM

TRIM28

Tripartite motif containing 28

Anti-TIF1β

rs4690220

(Proxy rs11724804 in GRAIL)

Chr4:980464

7.47 × 10-06

PM

IFIH1

Interferon induced with helicase C domain 1

Anti-MDA5

rs7535818

(Proxy rs2984920 in GRAIL)

Chr1:192545099

1.37 × 10-05

PM

NT5C1A

5'-nucleotidase, cytosolic 1A

Anti-NT5C1A

rs3129927

Chr6:32333827

3.74 × 10-48/2.06 × 10-129

DM/JDM/IIM

ABTB1

Ankyrin repeat and BTB (POZ) domain containing 1

Anti-Fer

rs4702698

Chr5:10517908

4.77 × 10-06

DM/JDM

HMGCR

3-hydroxy-3-methylglutaryl-CoA reductase

Anti-HMGCR

rs4921293

Chr5:159928876

8.27 × 10-06

DM/JDM

MORC3

MORC family CW-type zinc finger 3

Anti-NXP2

rs1008723

Chr17:38066267

9.05 × 10-06

DM/JDM

PMS1

Postmeiotic segregation increased 1

Anti-PMS1

    

PMS2

Postmeiotic segregation increased 2

Anti-PMS2

    

MLH1

MutL homolog 1

Anti-MLH1

    

PRKDC

Protein kinase, DNA-activated, catalytic polypeptide

Anti-DNA PKCS

    

EXOSC9

Exosome component 9

Anti-PMScl-75

    

EXOSC10

Exosome component 10

Anti-PMScl-100

    
  1. Single nucleotide polymorphisms (SNPs) were included if they reached the suggestive significance threshold (p < 2.25 × 10-5) for association with idiopathic inflammatory myopathies (IIM) in the Immunochip study published by Rothwell et al., 2015. Subset of autoantibody targets used in Disease Association Protein-Protein Link Evaluator (DAPPLE) formed by selecting one protein from each complex are shown in bold (n = 21). Subset of SNPs used in Gene Relationships Across Implicated Loci (GRAIL) analysis due to overlapping regions also shown in bold (n = 19) and proxies used for unrecognised SNPs are in brackets. aCHD4 also not included in GRAIL analysis due to overlapping regions (autoantibody targets = 27). Clinical groups included polymyositis (PM), adult/juvenile dermatomyositis (DM/JDM) and all sub-groups combined (IIM)